Применение внутривенных иммуноглобулинов в детской гематологии-онкологии и трансплантации гемопоэтических стволовых клеток: свойства и показания – опыт федеральных центров

This paper gives information on the structure of immunoglobulin molecules and the functions of each of them, as well as on the plasma levels of immunoglobulins. It provides basic requirements for the safety of intravenous immunoglobulins (IVVGs) and indications for their use in hematology/oncology and hematopoietic stem cell transplantation. Their doses, regimens, and possible adverse reactions are shown for a number of diseases. Moreover, the paper describes the experience with 10 % IVVGs in the federal center and gives brief clinical examples of the efficiency of using these agents.

• Publication year

  2015

• Venue

  Unknown venue

• Publication date

  2015-04-02

• Fields of study

  Medicine

• Identifiers
  DOI 10.17650/2311-1267-2014-0-3-44-50
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Effective treatment with intravenous immunoglobulins reduces autoreactive T-cell response in patients with CIDP

  2014cited by this paper
• Intravenous Immunoglobulins: In-Depth Review of Excipients and Acute Kidney Injury Risk

  2013cited by this paper
• Thromboembolic events associated with immunoglobulin treatment

  2013cited by this paper
• Direct Medical Costs of Liquid Intravenous Immunoglobulins in Children, Adolescents, and Adults in Spain

  2012cited by this paper
• Intravenous Immunoglobulin Replacement Therapy in the Treatment of Patients with Common Variable Immunodeficiency Disease

  2011cited by this paper
• Intravenous immunoglobulins – understanding properties and mechanisms

  2009cited by this paper
• Immunoglobulin prophylaxis in hematopoietic stem cell transplantation: systematic review and meta-analysis.

  2009cited by this paper
• Rituximab purging and maintenance combined with auto-SCT: long-term molecular remissions and prolonged hypogammaglobulinemia in relapsed follicular lymphoma

  2009cited by this paper
• Prolonged agammaglobulinemia despite unaltered B-cell lymphopoiesis after peritransplant-rituximab administration in a child.

  2008cited by this paper
• Intravenous immunoglobulin in the treatment of severe methotrexate-induced acral erythema.

  2008cited by this paper
• Guidelines on the use of intravenous immune globulin for neurologic conditions.

  2007cited by this paper
• Managing paraneoplastic neurological disorders.

  2006cited by this paper
• Opsoclonus myoclonus syndrome in neuroblastoma a report from a workshop on the dancing eyes syndrome at the advances in neuroblastoma meeting in Genoa, Italy, 2004.

  2005cited by this paper
• Antineuronal antibodies in patients with neuroblastoma and paraneoplastic opsoclonus-myoclonus.

  2000cited by this paper
• Anti-Hu antibody in a neuroblastoma-associated paraneoplastic syndrome.

  1994cited by this paper
• Immunomodulatory and antimicrobial efficacy of intravenous immunoglobulin in bone marrow transplantation.

  1990cited by this paper
• Treatment of fever and neutropenia with antibiotics versus antibiotics plus intravenous gammaglobulin in childhood leukemia

  1989cited by this paper
• Transient reversal of thrombocytopenia in idiopathic thrombocytopenic purpura by high-dose intravenous gamma globulin.

  1982cited by this paper

• No citing papers are available for this paper.